Friday Program

Education Session | Lunch Debates | EHA / ESH Joint Symposium | Meet-the-Expert | Opening Ceremony | Molecular Hematopoiesis Workshop | Poster Session I

LUNCH DEBATE
11:30 – 12:30, Hall A1

CHRONIC LYMPHOCYTIC LEUKEMIA THERAPY: IS INTENSIVE UP-FRONT THERAPY JUSTIFIED?
Chair: R Foà (Università "La Sapienza", Rome, Italy)

YES
S Stilgenbauer (University of Ulm, Ulm, Germany)
NO
E Montserrat (Hospital Clinic, Barcelona, Spain)

LUNCH DEBATE
11:30 – 12:30, Hall A2

SHOULD INTERIM POSITRON EMISSION TOMOGRAPHY BE USED TO ADAPT THERAPY IN AGGRESSIVE NON-HODGKIN LYMPHOMA?
Chair: P Zinzani (Institute of Hematology "Seràgnoli", Bologna, Italy)

YES
C Haioun (University Hospital Henri Mondov, Creteil, France)
NO
L Trumper (University of Göttingen, Göttingen, Germany)

LUNCH DEBATE
11:30 – 12:30, Auditorium 1

INHIBITOR DEVELOPMENT IN PATIENTS WITH HEMOPHILIA A: IS THERE A DIFFERENCE IN INCIDENCE BETWEEN PLASMA DERIVED AND RECOMBINANT PRODUCTS?
Chair: P Mannucci (University of Milan, Milan, Italy)

YES
E Chalmers (Royal Hospital for Sick Children Glasgow, Glasgow,United Kingdom)
NO
H van den Berg (Meander Medical Centre, Baarn, The Netherlands)